KEI has joined unions, NGOs and payors on a letter sent to Senator Grassley and Sen. Feinstein, the chair and ranking member of the Judiciary Committee, thanking them for their support of the Creating and Restoring Equal Access to Equivalent… Continue Reading
As reported by Knowledge Ecology International (KEI) in May 2018, “[o]n 25 May 2018, the World Trade Organization (WTO) published a joint submission (IP/C/W/643) by China and South Africa to the TRIPS Council on Promoting Public Health Through Competition Law… Continue Reading
(Update: The NIH provided a response to our comments on July 16, 2018) Below are comments sent by KEI, UACT and HealthGap, regarding a proposed exclusive license to Morphiex Biotherapeutics, an entity for which little is known. The license concerns… Continue Reading
The revised Chair’s text (SCCR/36/6) is very responsive to the broadcasters, and mostly hostile to the civil society groups’ positions, on issues such as term and exceptions, and extending the right to materials delivered over the Internet. One bright spot… Continue Reading
First: Deferred transmission. What is a deferred transmission? Here are the definitions in Daren Tang’s (the Chair of the SCCR) text of the treaty. Available here: http://www.wipo.int/edocs/mdocs/copyright/en/sccr_35/sccr_35_12.pdf: (f) “near simultaneous transmission” means a transmission for the reception by the public… Continue Reading
On May 28, 2018, at the opening of a five day to talks at the 36th WIPO Standing Committee on Copyright and Related Rights (SCCR), 11 civil society and library groups sent a letter to negotiators expressing deep concerns over… Continue Reading
The below are comments were filed by KEI and HealthGap on May 22, 2018, regarding a proposed NIH exclusive license on patents for the treatment and diagnosis of Crohn’s Disease, Ulcerative Colitis, Asthma, Psoriasis and Biliary Cirrhosis to Precision IBD… Continue Reading
On May 18, 2018 KEI requested that the Department of Health and Human Services (HHS) investigate the failure to disclose National Institutes of Health (NIH) funding in four patents on Vizamyl (INN flutemetamol F 18), which is used to evaluate… Continue Reading
On Wed, May 16, 2018, the House Ways & Means Committee held a markup on HR. 5773, a bill dealing with the opioid crisis, which would require Medicare prescription drug plans to establish drug management programs for at-risk beneficiaries. Representative… Continue Reading
These are provisions on the right to be forgotten in the European Union’s General Data Protection Regulation (GDPR). (KEI does not support the right to be forgotten). http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679&from=EN REGULATION (EU) 2016/679 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of… Continue Reading